| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1980) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | A11CC06 |
| UNII: | T0WXW8F54E |
| InChI Key | JWUBBDSIWDLEOM-DTOXIADCSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C27H46O3 |
| Molecular Weight | 418.66 |
| AlogP | 6.73 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 40.46 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 29.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Vitamin D receptor agonist | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group I
Nuclear hormone receptor subfamily 1 group I member 1
|
600 | - | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hyperparathyroidism, Secondary | 4 | D006962 | ClinicalTrials |
| Myocardial Infarction | 3 | D009203 | ClinicalTrials |
| Sleep Apnea, Obstructive | 2 | D020181 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Acute Kidney Injury | 2 | D058186 | ClinicalTrials |
| Vitamin D Deficiency | 2 | D014808 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 19356-17-3 |
| ChEBI | 17933 |
| ChEMBL | CHEMBL1040 |
| DrugBank | DB00146 |
| DrugCentral | 464 |
| EPA CompTox | DTXSID0022721 |
| FDA SRS | T0WXW8F54E |
| Human Metabolome Database | HMDB0003550 |
| Guide to Pharmacology | 6921 |
| KEGG | C01561 |
| PDB | VDY |
| PubChem | 6441383 |
| SureChEMBL | SCHEMBL3296 |
| ZINC | ZINC000004474414 |
| CAS NUMBER | 19356-17-3 |
| ChEMBL | CHEMBL3544909 |
| FDA SRS | P6YZ13C99Q |
| Guide to Pharmacology | 6921 |
| PubChem | 6441383 |
| SureChEMBL | SCHEMBL63580 |